ATLANTA, GA—More than a decade after the TACT trial reported an astonishing reduction in cardiovascular events post-MI with heavy metal chelation in a subset of diabetic patients, the TACT2 trial, ...

CHELATION THERAPY HAS been around for decades as a treatment for toxic metal poisoning. But, there have also been claims that the therapy could help several other conditions. Experts aren't so sure.

Chelation therapy consists of a series of IV administrations of disodium or calcium ethylenediaminetetraacetic acid (EDTA) mixed with minerals and vitamins. Typically, patients recline in a chair in ...

Jan. 22, 2003 -- Ethylenedinitrilo tetraacetic acid (EDTA) chelation therapy presumably reduces the progression of renal disease in patients with high normal lead levels and without diabetes, ...

I. A Brief History of EDTA Chelation for Cardiovascular Disease In its early years the AAMP mounted one of the first "direct-to-consumer" drug advertising campaigns in the form of "An Open Letter to ...

In patients with CAD and history of myocardial infarction and diabetes, edetate disodium chelation is not effective for decreasing cardiovascular events. Edetate disodium (EDTA) chelation is not ...

ATLANTA -- Chelation to remove lead and other heavy metals didn't improve outcomes for type 2 diabetes patients after myocardial infarction (MI), the TACT2 trial showed. Cumulative incidence of time ...

Between 2002 and 2007, use of chelation therapy to treat heart disease and other conditions grew in the United States by nearly 68% to 111,000 people. 1 As of the start of the TACT Study in 2001, it ...

The products: At a time when heavy metals are showing up in tuna steaks and toy cabooses, it’s only natural to worry about the metals in our bodies. The good news: Americans have much less lead in ...

With a result that is likely to surprise and baffle much of the mainstream medical community, a large NIH-sponsored trial has turned up the first substantial evidence in support of chelation therapy ...

PNEUMONOCONIOSIS associated with heavy-metal inhalation has long resisted most forms of therapy. The development of chelating agents offers a new approach to this problem. This report concerns our ...